At 5.60% CAGR, Global Male Infertility Market Size & Share to Surpass US$ 3.55 Billion by 2027 | Industry Trends, Growth, Share, Opportunities, Statistics, Analysis & Forecast Report by IMARC Group
Global Male Infertility Market Overview (2022-2027)
• Historical Market Size (2021): US$ 3.55 Billion
• Forecast CAGR (2022-2027): 5.60%
• Forecast Market Size (2027): US$ 4.97 Billion
Impact of COVID-19:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request For Sample Report https://www.imarcgroup.com/male-infertility-market/requestsample
What is a Male Infertility Market?
Male infertility represents a disease of the reproductive system that lowers the chance of the affected individual to impregnate a fertile woman. It can occur, owing to blockages, abnormal sperm function, and low sperm production that prevents the delivery of sperm.
Some factors that may contribute to male infertility include genetic defects, undescended testicles, sperm illnesses, injuries, diabetes, or infections, such as chlamydia, gonorrhea, mumps, HIV, etc. It can be treated by vasoepididymostomy, hormone therapy, and assisted reproductive technology (ART) procedures, including in vitro fertilization (IVF) and varicocele surgery. These procedures aid in enhancing the reproductive health of males, restoring testosterone levels, and improving the quality of sperm to enable pregnancy.
What are the major market drivers in the Male Infertility Market ?
The growing incidences of chronic diseases, such as diabetes, obesity, hypertension, etc., on account of sedentary lifestyles and lack of physical activities, are primarily driving the male infertility market. Additionally, the escalating demand for ART procedures, such as IVF, that involve the adoption of previously frozen sperms is further catalyzing the market growth.
Besides this, the rising utilization of deoxyribonucleic acid (DNA) fragmentation techniques and computer-assisted semen analysis to diagnose hypospermia, measure semen volume, and determine male infertility is acting as another significant growth-inducing factor.
Moreover, the easy availability of several infertility treatment drugs, procedures, devices, etc., the increasing workload and the accompanying stress, and unhealthy habits, such as excessive consumption of drugs, alcohol, smoking, etc., are also positively influencing the global market.
Apart from this, the launch of various favorable policies by government bodies for improving reimbursement scenarios for infertility-related treatments and enhancing the safety of patient data is propelling the market growth. Furthermore, extensive R&D activities are anticipated to fuel the male infertility market over the forecasted period.
Regional Insights:
- Asia Pacific
- North America
- Europe
- Middle East and Africa
- Latin America
On the geographical front, Asia Pacific enjoys the leading position in the market. This can be attributed to the rising establishment of international companies in the region, on account of low manufacturing costs and cheap labor.
List of Major Key Players:
The major players in the market are Andrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
